{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T20:09:00Z","timestamp":1787947740777,"version":"build-2784847793"},"reference-count":20,"publisher":"SLACK, Inc.","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Psychosoc Nurs Ment Health Serv"],"published-print":{"date-parts":[[2018,5]]},"abstract":"<jats:p>\n            Aripiprazole is a third-generation atypical antipsychotic medication, which is widely used for various psychiatric disorders across the lifespan. Aripiprazole can cause side effects including headache, insomnia, agitation, nervousness, lightheadedness, dizziness, somnolence, akathisia, and weight gain. Neutropenia is a less frequent side effect of aripiprazole. The current article reviews a case of a 10-year-old African American boy who developed neutropenia with aripiprazole. It is important for clinicians to be aware of this rare side effect. [\n            <jats:italic>Journal of Psychosocial Nursing and Mental Health Services, 56<\/jats:italic>\n            (5), 21\u201324.]\n          <\/jats:p>","DOI":"10.3928\/02793695-20180419-02","type":"journal-article","created":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T18:29:21Z","timestamp":1525199361000},"page":"21-24","source":"Crossref","is-referenced-by-count":10,"title":["Aripiprazole-Induced Neutropenia: Case Report and Literature Review"],"prefix":"10.3928","volume":"56","author":[{"given":"Tricia","family":"Felin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadiq","family":"Naveed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amna M.","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2308","reference":[{"key":"e_1_3_1_2_1","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1998.tb141414.x"},{"key":"e_1_3_1_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2006.07.003"},{"key":"e_1_3_1_4_1","volume-title":"Clinical handbook of psychotropic drugs for children and adolescents","author":"Elbe D.","year":"2015","unstructured":"Elbe D., Bezchlibnyk-Butler K.Z., Virani A.S., Procyshyn R.M. (Eds.). (2015). Clinical handbook of psychotropic drugs for children and adolescents (3rd ed.). Cambridge, MA: Hogrefe.","edition":"3"},{"key":"e_1_3_1_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.917"},{"key":"e_1_3_1_6_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.41.2.150"},{"key":"e_1_3_1_7_1","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.10453"},{"key":"e_1_3_1_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200103000-00007"},{"key":"e_1_3_1_9_1","doi-asserted-by":"publisher","DOI":"10.3109\/00048674.2010.524624"},{"key":"e_1_3_1_10_1","doi-asserted-by":"publisher","DOI":"10.4306\/pi.2013.10.4.428"},{"key":"e_1_3_1_11_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.1561"},{"key":"e_1_3_1_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(03)00050-1"},{"key":"e_1_3_1_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2005.08.005"},{"key":"e_1_3_1_14_1","unstructured":"Otsuka America Pharmaceutical Inc. (2014). Abilify (aripiprazole): Highlights of prescribing information . Retrieved from https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/021436s038 021713s030 021729s022 021866s023lbl.pdf"},{"key":"e_1_3_1_15_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740330902835493"},{"key":"e_1_3_1_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-013-0426-8"},{"key":"e_1_3_1_17_1","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.v10n0612c"},{"key":"e_1_3_1_18_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.1059"},{"key":"e_1_3_1_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2003.03.009"},{"key":"e_1_3_1_20_1","volume-title":"Abilify (aripiprazole) prescribing information.","author":"Squibb B.M.","year":"2012","unstructured":"Squibb B.M. (2012). Abilify (aripiprazole) prescribing information. Tokyo, Japan: Otsuka Pharmaceutical."},{"key":"e_1_3_1_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/pcn.12466"}],"container-title":["Journal of Psychosocial Nursing and Mental Health Services"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.healio.com\/doiresolver?doi=10.3928\/02793695-20180419-02","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T04:15:59Z","timestamp":1683087359000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.healio.com\/doi\/10.3928\/02793695-20180419-02"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["10.3928\/02793695-20180419-02"],"URL":"https:\/\/doi.org\/10.3928\/02793695-20180419-02","relation":{},"ISSN":["0279-3695","1938-2413"],"issn-type":[{"value":"0279-3695","type":"print"},{"value":"1938-2413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5]]}}}